MS4A6A
Membrane-spanning 4-domains subfamily A member 6A
Also known as: CD20L3, M4A6A_HUMAN, MS4A6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H2W1
- Gene
- MS4A6A
- Ensembl
- ENSG00000110077
- Chromosome
- 11
- Canonical length
- 248 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
This gene encodes a member of the membrane-spanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. The gene encoding this protein is localized to 11q12.1, among a cluster of family members. Alternative splicing of this gene results in several transcript variants that encode different protein isoforms. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
248 residues, UniProt reviewed canonical sequence.
>Q9H2W1|MS4A6A
1 MTSQPVPNET IIVLPSNVIN FSQAEKPEPT NQGQDSLKKH LHAEIKVIGT IQILCGMMVL
61 SLGIILASAS FSPNFTQVTS TLLNSAYPFI GPFFFIISGS LSIATEKRLT KLLVHSSLVG
121 SILSALSALV GFIILSVKQA TLNPASLQCE LDKNNIPTRS YVSYFYHDSL YTTDCYTAKA
181 SLAGTLSLML ICTLLEFCLA VLTAVLRWKQ AYSDFPGSVL FLPHSYIGNS GMSSKMTHDC
241 GYEELLTSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MS4A6A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 133 nTPM
Expression across tissuesHPA
Tissue
- liver: 133 nTPM
- lymph node: 126 nTPM
- spleen: 125 nTPM
- adipose tissue: 88 nTPM
- placenta: 82 nTPM
- gallbladder: 73 nTPM
Single-cell type
- kupffer cells: 3,075 nCPM
- macrophages: 792 nCPM
- monocytes: 666 nCPM
- cdc: 629 nCPM
- monocyte progenitors: 556 nCPM
- hofbauer cells: 465 nCPM
Immune cell
- classical monocyte: 1,399 nTPM
- total PBMC: 943 nTPM
- myeloid DC: 814 nTPM
- plasmacytoid DC: 559 nTPM
- basophil: 525 nTPM
- intermediate monocyte: 459 nTPM
Brain region
- white matter: 25 nTPM
- medulla oblongata: 20 nTPM
- choroid plexus: 19 nTPM
- pons: 18 nTPM
- thalamus: 15 nTPM
- spinal cord: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.95
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.46
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MS4A6A as an antibody target. Whether an autoantibody or antibody against MS4A6A could matter depends on whether native MS4A6A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MS4A6A is annotated at the cell surface, where native MS4A6A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MS4A6A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...